These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 2983238)
1. [AIDS and the current significance of serological studies for the presence of antibodies against LAV/HTLV III]. van Gestel WJ Ned Tijdschr Geneeskd; 1985 Feb; 129(5):233-4. PubMed ID: 2983238 [No Abstract] [Full Text] [Related]
2. [Sero-epidemiology of HTLV-III/LAV antibodies in French-speaking Switzerland]. Stroun J Rev Med Suisse Romande; 1985 Nov; 105(11):1055-7. PubMed ID: 3003866 [No Abstract] [Full Text] [Related]
3. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus. Yarchoan R; Redfield RR; Broder S J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028 [TBL] [Abstract][Full Text] [Related]
4. Acquired immune deficiency syndrome (AIDS) HTLV III/LAV; the causal agent and modes of transmission. Smithies A Health Bull (Edinb); 1986 Jul; 44(4):234-8. PubMed ID: 3017891 [No Abstract] [Full Text] [Related]
5. [Antibodies against human T-cell leukemia virus (HTLV) in male homosexuals with acquired immunodeficiency syndrome]. Kurth R; Brede HD; Bergmann L; Mitrou PS; Helm EB; Stille W MMW Munch Med Wochenschr; 1983 Dec; 125(48):1119-23. PubMed ID: 6318098 [No Abstract] [Full Text] [Related]
6. AIDS: the significance of anti-HTLV-III antibodies. Robinson PA; Brough J; Haddy L; Belshe RB; Khakoo R; Stevenson MM W V Med J; 1985 Sep; 81(9):194-7. PubMed ID: 2998098 [No Abstract] [Full Text] [Related]
7. HTLV-III and the etiology of AIDS. Gallo RC; Sarngadharan MG; Popovic M; Shaw GM; Hahn B; Wong-Staal F; Robert-Guroff M; Zaki Salahuddin S; Markham PD Prog Allergy; 1986; 37():1-45. PubMed ID: 3008160 [No Abstract] [Full Text] [Related]
8. Testing for HTLV-III/LAV antibody. Holston JL Ala J Med Sci; 1986 Jul; 23(3):269-71. PubMed ID: 3019171 [No Abstract] [Full Text] [Related]
9. [A simple method for determination of antibodies to AIDS associated virus (HTLV-III)]. Biberfeld G; Bredberg-Rådén U; Böttiger B; Biberfeld P; Morfeldt-Månsson L; Suni J; Vaheri A; Saxinger C; Gallo R Lakartidningen; 1984 Sep; 81(39):3482-3. PubMed ID: 6092800 [No Abstract] [Full Text] [Related]
11. [Hospital hygiene. Notice of the Expert Federal Commission for AIDS on procedures to adopt in regard to patients with AIDS and to persons carrying anti-LAV/HTLV-III antibodies]. Krankenpfl Soins Infirm; 1986 May; 79(5):74-5. PubMed ID: 3012197 [No Abstract] [Full Text] [Related]
12. [HTLV-III infections and AIDS--current epidemiology and serology]. Biberfeld G; Böttiger M; Biberfeld P Lakartidningen; 1985 May; 82(20):1867-70. PubMed ID: 2987632 [No Abstract] [Full Text] [Related]
13. A stage model of HTLV-III LAV infection in intravenous drug users. Des Jarlais DC; Friedman SR; Spira TJ; Zolla-Pazner S; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J NIDA Res Monogr; 1986; 67():328-34. PubMed ID: 3018574 [No Abstract] [Full Text] [Related]
14. [Specific antibodies against human T cell leukemia virus found in AIDS patients]. Nagy K; Clapham P; Weiss R; Földes I Orv Hetil; 1984 Jun; 125(26):1557-60. PubMed ID: 6330642 [No Abstract] [Full Text] [Related]
15. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome. Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287 [TBL] [Abstract][Full Text] [Related]
16. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168 [TBL] [Abstract][Full Text] [Related]
18. Transmission of acquired immune deficiency syndrome (AIDS) by a blood transfusion given in 1979 in Israel. Kleinman Y; Yust I; Maayan S; Rave D; Merdler C; Michaeli D; Schlesinger M Isr J Med Sci; 1986 May; 22(5):404-7. PubMed ID: 3017890 [TBL] [Abstract][Full Text] [Related]
19. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico]. Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666 [No Abstract] [Full Text] [Related]